The Food and Drug Administration has declined to approve an experimental drug for schizophrenia and bipolar disorder developed by Forest Labs and Gedeon Richter, a Hungarian drug company, the two said Thursday.
The Food and Drug Administration has approved the latest drug in BD's Simplist line, the company said Thursday.
The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.
Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.
Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.
Indian drug maker Wockhardt has received tentative approval from the Food and Drug Administration for a generic version of a Pfizer psychiatric drug.
Generic drug maker Amneal has launched three new liquid drugs, the company said Monday.
The Food and Drug Administration has approved a preventive treatment made by Strativa Pharmaceuticals for...
The Food and Drug Administration has declined to approve a drug made by Strativa Pharmaceuticals...